YMMUNO BIOTECH
A Biotech start-up focused on developing new science-based products. Immunotherapies and Orally passive immunization is our cup of tea. Nowadays we are working on a new therapy to improve life quality in Crohn´s Disease patients and improving a new methodology to reduce the use of antibiotics in hospitalized elderly patients.
YMMUNO BIOTECH
Social Links:
Industry:
Biotechnology Dietary Supplements Pharmaceutical
Founded:
2019-02-05
Address:
Florianópolis, Santa Catarina, Brazil
Country:
Brazil
Total Employee:
1+
Status:
Active
Contact:
+5548999187299
Email Addresses:
[email protected]
Total Funding:
60 K BRL
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
FAPESC - Fundação de Amparo à Pesquisa e Inovação
FAPESC - Fundação de Amparo à Pesquisa e Inovação investment in Seed Round - Ymmuno Biotech